• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年流感患者30天死亡率的相关危险因素

Risk Factors Associated with 30-Day Mortality in Older Patients with Influenza.

作者信息

Guesneau Charles, Boureau Anne Sophie, Bourigault Céline, Berrut Gilles, Lepelletier Didier, de Decker Laure, Chapelet Guillaume

机构信息

Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France.

Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance Bacterienne), Institut de Recherche en Santé (IRS2), 22 Boulevard Bénoni-Goullin, F-44200 Nantes, France.

出版信息

J Clin Med. 2021 Aug 11;10(16):3521. doi: 10.3390/jcm10163521.

DOI:10.3390/jcm10163521
PMID:34441817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8396973/
Abstract

BACKGROUND

Influenza is a common viral condition, but factors related to short-term mortality have not been fully studied in older adults. Our objective was to determine whether there is an association between geriatric factors and 30-day mortality.

METHODS

This was a retrospective cohort design. All patients aged 75 years and over, with a diagnosis of influenza confirmed by a positive RT-PCR, were included. The primary endpoint was death within the 30 days after diagnosis.

RESULTS

114 patients were included; 14 (12.3%) patients died within 30 days. In multivariate analysis these patients were older (OR: 1.37 95% CI (1.05, 1.79), = 0.021), and had a lower ADL score (OR: 0.36 95% CI (0, 17; 0.75), = 0.006), and a higher SOFA score (OR: 2.30 95% CI (1.07, 4.94), = 0.03). Oseltamivir treatment, initiated within the first 48 h, was independently associated with survival (OR: 0.04 95% CI (0.002, 0.78), = 0.034).

CONCLUSIONS

Identification of mortality risk factors makes it possible to consider specific secondary prevention measures such as the rapid introduction of antiviral treatment. Combined with primary prevention, these measures could help to limit the mortality associated with influenza in older patients.

摘要

背景

流感是一种常见的病毒感染性疾病,但老年人短期死亡率相关因素尚未得到充分研究。我们的目的是确定老年因素与30天死亡率之间是否存在关联。

方法

这是一项回顾性队列研究设计。纳入所有年龄在75岁及以上、经逆转录聚合酶链反应(RT-PCR)阳性确诊为流感的患者。主要终点是诊断后30天内死亡。

结果

共纳入114例患者;14例(12.3%)患者在30天内死亡。多因素分析显示,这些患者年龄较大(比值比:1.37,95%置信区间(1.05,1.79),P = 0.021),日常生活活动能力(ADL)评分较低(比值比:0.36,95%置信区间(0.17,0.75),P = 0.006),序贯器官衰竭评估(SOFA)评分较高(比值比:2.30,95%置信区间(1.07,4.94),P = 0.03)。在发病48小时内开始使用奥司他韦治疗与生存独立相关(比值比:0.04,95%置信区间(0.002,0.78),P = 0.034)。

结论

识别死亡风险因素有助于考虑采取特定的二级预防措施,如迅速启动抗病毒治疗。结合一级预防,这些措施有助于降低老年患者流感相关死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc1/8396973/44b0c36447a0/jcm-10-03521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc1/8396973/44b0c36447a0/jcm-10-03521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebc1/8396973/44b0c36447a0/jcm-10-03521-g001.jpg

相似文献

1
Risk Factors Associated with 30-Day Mortality in Older Patients with Influenza.老年流感患者30天死亡率的相关危险因素
J Clin Med. 2021 Aug 11;10(16):3521. doi: 10.3390/jcm10163521.
2
Effect of antiviral treatment in older patients hospitalized with confirmed influenza.老年确诊流感患者抗病毒治疗的效果。
Antiviral Res. 2020 Jun;178:104785. doi: 10.1016/j.antiviral.2020.104785. Epub 2020 Mar 29.
3
[A 180-day mortality predictive score based on frailty syndrome in elderly patients with sepsis: a Logistic regression analysis model].基于脓毒症老年患者衰弱综合征的180天死亡率预测评分:Logistic回归分析模型
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):257-262. doi: 10.3760/cma.j.cn121430-20201027-00688.
4
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.克拉霉素-萘普生-奥司他韦联合用药治疗甲型(H3N2)流感感染住院患者的疗效:一项开放标签随机对照IIb/III期试验
Chest. 2017 May;151(5):1069-1080. doi: 10.1016/j.chest.2016.11.012. Epub 2016 Nov 22.
5
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.
6
Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).流感耐药性信息研究(IRIS)中住院的免疫功能低下流感患者的病毒 shedding 及对奥司他韦的敏感性 。 注:这里“shedding”常见释义为“脱落;摆脱;散发”等,结合语境,在医学领域可能是指病毒排出等意思,因未明确准确含义,暂保留英文。
Antivir Ther. 2015;20(6):633-42. doi: 10.3851/IMP2957. Epub 2015 Apr 7.
7
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.在有流感并发症风险的青少年和成年门诊患者中早期使用巴洛沙韦治疗(CAPSTONE-2):一项随机、安慰剂对照、3 期临床试验。
Lancet Infect Dis. 2020 Oct;20(10):1204-1214. doi: 10.1016/S1473-3099(20)30004-9. Epub 2020 Jun 8.
8
Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.奥司他韦对青少年及成年流感患者继发并发症发生率的影响:一项基于人群的回顾性研究结果
Curr Med Res Opin. 2007 Dec;23(12):2961-70. doi: 10.1185/030079907X242520.
9
Antiviral drugs in influenza: an adjunct to vaccination in some situations.流感抗病毒药物:在某些情况下作为疫苗接种的辅助手段。
Prescrire Int. 2006 Feb;15(81):21-30.
10
Effect of Early Oseltamivir Treatment on Mortality in Critically Ill Patients With Different Types of Influenza: A Multiseason Cohort Study.早期使用奥司他韦治疗对不同类型流感重症患者死亡率的影响:一项多季节队列研究
Clin Infect Dis. 2019 Nov 13;69(11):1896-1902. doi: 10.1093/cid/ciz101.

引用本文的文献

1
Understanding and improving vaccine efficacy in older adults.了解并提高老年人的疫苗效力。
Nat Aging. 2025 Aug;5(8):1455-1470. doi: 10.1038/s43587-025-00939-6. Epub 2025 Aug 14.
2
High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review.老年人(≥65 岁)中流感疾病的高临床负担:我们能否做得更好?系统文献回顾。
Adv Ther. 2023 Apr;40(4):1601-1627. doi: 10.1007/s12325-023-02432-1. Epub 2023 Feb 15.

本文引用的文献

1
Vaccines for preventing influenza in the elderly.用于预防老年人流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004876. doi: 10.1002/14651858.CD004876.pub4.
2
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
3
Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.流感病毒感染的离散动力学模型表明免疫存在年龄依赖性差异。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.00395-17. Print 2017 Dec 1.
4
Factors Associated with Lethal Outcome in Patients with Severe Form of Influenza.重症流感患者致死结局的相关因素
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2016 Nov 1;37(2-3):63-72. doi: 10.1515/prilozi-2016-0018.
5
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
6
Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico.墨西哥甲型H1N1流感感染患者死亡相关的危险因素
BMC Res Notes. 2015 Sep 11;8:432. doi: 10.1186/s13104-015-1349-8.
7
Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients.2013 - 2014年美国33家医院的重症流感:507例患者的并发症及死亡风险因素
Infect Control Hosp Epidemiol. 2015 Nov;36(11):1251-60. doi: 10.1017/ice.2015.170. Epub 2015 Jul 30.
8
Mortality prediction to hospitalized patients with influenza pneumonia: PO /FiO combined lymphocyte count is the answer.流感肺炎住院患者的死亡率预测:氧合指数(PO₂/FiO₂)联合淋巴细胞计数是答案。
Clin Respir J. 2017 May;11(3):352-360. doi: 10.1111/crj.12346. Epub 2015 Aug 11.
9
MARK-AGE biomarkers of ageing.衰老的MARK-AGE生物标志物。
Mech Ageing Dev. 2015 Nov;151:2-12. doi: 10.1016/j.mad.2015.03.006. Epub 2015 Mar 24.
10
Excess mortality among the elderly in European countries, December 2014 to February 2015.2014 年 12 月至 2015 年 2 月期间欧洲国家老年人的超额死亡率。
Euro Surveill. 2015 Mar 19;20(11):21065. doi: 10.2807/1560-7917.es2015.20.11.21065.